Study Materials. The term “Study Materials” shall mean the Study Drug, reagents and materials derived from subjects enrolled in the Study, including but not limited to: blood, serum and other biological materials. Access to Study Materials shall be limited to only those persons who are under the Principal Investigator’s direct control and who will only be using Study Materials for the Study. At no time shall any Study Materials be used for any purpose other than as described in the Protocol or transferred to any third party without Sponsor or SynteractHCR’s prior written consent. Upon termination or completion of the Study, the Institution and Principal Investigator shall return all unused Study Materials to the Sponsor or, at the Sponsor’s sole option and written direction, destroy such Study Materials.
Appears in 1 contract
Sources: Clinical Trial Agreement
Study Materials. The term “Study Materials” shall mean the Study Drug, reagents and materials derived from subjects enrolled in the Study, including but not limited to: blood, serum and other biological materials. Access to Study Materials shall be limited to only those persons who are under the Principal InvestigatorHealthcare Provider’s direct control and who will only be using Study Materials for the Study. At no time shall any Study Materials be used for any purpose other than as described in the Protocol or transferred to any third party without Sponsor or SynteractHCR’s prior written consent. Upon termination or completion of the Study, the Institution and Principal Investigator Healthcare Provider shall return all unused Study Materials to the Sponsor or, at the Sponsor’s sole option and written direction, destroy such Study MaterialsMaterials at Sponsor’s expense, upon prior written agreement with the Sponsor.
Appears in 1 contract
Sources: Clinical Trial Agreement